NCT04517838 2025-12-24Immune Response to Anti-HER2 Therapies in Patients With HER2-Positive Stage I-IV Breast CancerMayo ClinicRecruiting230 enrolled
NCT05447910 2025-06-15Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast CancerMayo ClinicTerminated21 enrolled